Literature DB >> 19357328

Using the whole cohort in the analysis of case-cohort data.

Norman E Breslow1, Thomas Lumley, Christie M Ballantyne, Lloyd E Chambless, Michal Kulich.   

Abstract

Case-cohort data analyses often ignore valuable information on cohort members not sampled as cases or controls. The Atherosclerosis Risk in Communities (ARIC) study investigators, for example, typically report data for just the 10%-15% of subjects sampled for substudies of their cohort of 15,972 participants. Remaining subjects contribute to stratified sampling weights only. Analysis methods implemented in the freely available R statistical system (http://cran.r-project.org/) make better use of the data through adjustment of the sampling weights via calibration or estimation. By reanalyzing data from an ARIC study of coronary heart disease and simulations based on data from the National Wilms Tumor Study, the authors demonstrate that such adjustment can dramatically improve the precision of hazard ratios estimated for baseline covariates known for all subjects. Adjustment can also improve precision for partially missing covariates, those known for substudy participants only, when their values may be imputed with reasonable accuracy for the remaining cohort members. Links are provided to software, data sets, and tutorials showing in detail the steps needed to carry out the adjusted analyses. Epidemiologists are encouraged to consider use of these methods to enhance the accuracy of results reported from case-cohort analyses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357328      PMCID: PMC2768499          DOI: 10.1093/aje/kwp055

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Analysis of case-cohort designs.

Authors:  W E Barlow; L Ichikawa; D Rosner; S Izumi
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

2.  Influence function based variance estimation and missing data issues in case-cohort studies.

Authors:  S D Mark; H Katki
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

3.  Robust variance estimation for the case-cohort design.

Authors:  W E Barlow
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Design options in epidemiologic research. An update.

Authors:  O Miettinen
Journal:  Scand J Work Environ Health       Date:  1982       Impact factor: 5.024

5.  A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  M L Rasmussen; A R Folsom; D J Catellier; M Y Tsai; U Garg; J H Eckfeldt
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

6.  Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease.

Authors:  R Li; E Boerwinkle; A F Olshan; L E Chambless; J S Pankow; H A Tyroler; M Bray; G S Pittman; D A Bell; G Heiss
Journal:  Atherosclerosis       Date:  2000-04       Impact factor: 5.162

7.  Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.

Authors:  G J D'Angio; N Breslow; J B Beckwith; A Evans; H Baum; A deLorimier; D Fernbach; E Hrabovsky; B Jones; P Kelalis
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

8.  The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease.

Authors:  Vahid Afshar-Kharghan; Nevenka Matijevic-Aleksic; Chul Ahn; Eric Boerwinkle; Kenneth K Wu; José A López
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Incidence of leukemia, lymphoma, and multiple myeloma in Czech uranium miners: a case-cohort study.

Authors:  Vladimír Rericha; Michal Kulich; Robert Rericha; David L Shore; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

View more
  66 in total

1.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

2.  Comparison of estimators in nested case-control studies with multiple outcomes.

Authors:  Nathalie C Støer; Sven Ove Samuelsen
Journal:  Lifetime Data Anal       Date:  2012-03-02       Impact factor: 1.588

3.  Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.

Authors:  Stephen R Cole; Michael G Hudgens; Phyllis C Tien; Kathryn Anastos; Lawrence Kingsley; Joan S Chmiel; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2012-02-01       Impact factor: 4.897

4.  Efficient Estimation of Semiparametric Transformation Models for Two-Phase Cohort Studies.

Authors:  Donglin Zeng; D Y Lin
Journal:  J Am Stat Assoc       Date:  2014-01-01       Impact factor: 5.033

5.  Mortality among military participants at the 1957 PLUMBBOB nuclear weapons test series and from leukemia among participants at the SMOKY test.

Authors:  Glyn G Caldwell; Matthew M Zack; Michael T Mumma; Henry Falk; Clark W Heath; John E Till; Heidi Chen; John D Boice
Journal:  J Radiol Prot       Date:  2016-06-29       Impact factor: 1.394

6.  Antiretroviral Drug Concentrations in Breastmilk, Maternal HIV Viral Load, and HIV Transmission to the Infant: Results From the BAN Study.

Authors:  Nicole L Davis; Amanda Corbett; Josh Kaullen; Julie A E Nelson; Charles S Chasela; Dorothy Sichali; Michael G Hudgens; William C Miller; Denise J Jamieson; Athena P Kourtis
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-01       Impact factor: 3.731

7.  Calibration weighted estimation of semiparametric transformation models for two-phase sampling.

Authors:  Youyi Fong; Peter Gilbert
Journal:  Stat Med       Date:  2015-02-04       Impact factor: 2.373

8.  Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials.

Authors:  Peter B Gilbert; Xuesong Yu; Andrea Rotnitzky
Journal:  Stat Med       Date:  2013-10-09       Impact factor: 2.373

9.  Marginal Structural Cox Models with Case-Cohort Sampling.

Authors:  Hana Lee; Michael G Hudgens; Jianwen Cai; Stephen R Cole
Journal:  Stat Sin       Date:  2016-04       Impact factor: 1.261

10.  Evaluating prognostic accuracy of biomarkers in nested case-control studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  Biostatistics       Date:  2011-08-19       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.